Category: ビデオ

TranscriptMany pharmaceutical industry professionals once considered standardizing regulatory writing style conventions unnecessary and time-consuming. However, the industry now recognizes its benefits for maximizing efficiency during regulatory submission development. The benefits of using style guides and lexicons in medical writing include:  The Certara Drug Development Solutions Document Quality group is experienced in creating and maintaining style guides and … Continued

Transcript: Hello, and welcome to Certara Talks. I’m Doctor Suzanne Minton, and I’m a director of content strategy at Certara . Today, I’m talking to my colleague, doctor Joshua Apgar. Joshua, welcome to Certara talks. Would you like to introduce yourself? Sure. Thank you. I’m, Josh Apgar, one of the co founders at applied Balmain, … Continued

In this video, Dr. Mark Sullivan, Managing Director of Medicines Development for Global Health, explains how Certara’s model-informed drug development expertise was used to support developing moxidectin as a treatment for onchocerciasis “river blindness.” Transcript The role that Certara has played has really been a as an as a integral part of our drug development … Continued

Transcript: Did you know that eighty percent of life sciences data is unstructured? This data is messy, difficult to search, often resides in silos. Having unstructured data means that you could be missing valuable insights that can inform prioritizing new molecules for designing, executing, or submitting clinical trials. The proliferation of powerful AI models such … Continued

In this episode of Certara Talks, Jeff Abolafia, Kristin Kelly, and Julie Ann Hood recap their fantastic presentations from PHUSE US Connect earlier this month. The team covered inspirational and innovative topics, and Julie Ann and Jeffrey won Best in Stream for their presentations ‘Sowing Seeds of Inspiration: Letters to a Pre-Scientist’ and ‘Future Clinical … Continued

Transcript:In pharmaceutical research and development, R&D, companies utilize biosimulation and PBPK modeling technologies to identify and develop new therapeutic agents. Biosimulation technology holds immense potential for expediting FDA approvals while predicting toxicities and drug to drug interactions. Within the field of oncology, kinase inhibitor drug have shown efficacy in targeting complex diseases with over fifty … Continued

Transcript: Scientists in your organization must pour over and draw conclusion. From growing volumes of data at the study, program, and portfolio level. They need a tool developed by scientists, four scientists to identify trends, drive data driven decisions, and communicate findings. Introducing Send Explorer by Certara. Empower your scientists.

Transcript: The Certara community and interdisciplinary industry experts and scientists from model and form drug development bio simulation, clinical pharmacology, regulatory science, and software development come together for Certainty. Certara’s first annual client summit. This coming May fourteenth through sixteenth in Philadelphia at Convene. We will unite to share future visions, strategies, industry trends, and … Continued

Transcript: I’ve joined companies both blueprint medicines and score therapeutics is one of the first employees with no infrastructure in place. So I have with chemists and biologists evaluated products on the markets and the conclusion both times was that Certara three sixty really is the best product out there. When you just ask a … Continued